Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.

Topics:  therapy   lung cancer   
  • Immune therapy scores big win against lung cancer in study
    CHICAGO — New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system ... at a Texas school have found out just how hard it is to live within a budget thanks to a real-world simulation.
    04/16/2018 - 2:58 am | View Link
  • Merck drug results suggest it will extend its lead in lung cancer; Bristol-Myers shares drop
    The medicines, which help unleash the immune ... patients' PD-L1 status. The trial focused on a measure known as overall survival – how long patients live – as well as one known as progression-free survival, or how long patients live without their ...
    04/16/2018 - 2:58 am | View Link
  • Lung Cancer Patients Live Longer With Immune Therapy
    The odds of survival can greatly improve for people with the most common type of lung cancer if, along with the usual chemotherapy, they are also given a drug that activates the immune system, a major new study has shown. The findings should change medical ...
    04/16/2018 - 2:49 am | View Link
  • New Drug Combinations Improve Survival in Lung Cancer
    Combining new immune-boosting cancer drugs ... they welcome advances in treating lung cancer, the deadliest type of tumor. “We’re talking about people living significantly longer than they would otherwise live,” said Dr. Nasser Altorki ...
    04/16/2018 - 2:34 am | View Link
  • 'We are going to have lung cancer patients living longer and better:' A new kind of cancer treatment is about to change how we treat the disease
    New cancer treatments ... much PD-L1 the patients expressed. Data on overall survival was not included, but in March, Roche said the combination helped people with advanced non-squamous non-small cell lung cancer "live significantly longer" than those ...
    04/16/2018 - 2:33 am | View Link
  • More
  • Lung Cancer News -- ScienceDaily
    Apr. 2, 2018 — Lung cancer, a leading killer, has been hard to target with drugs. A team took a metabolic approach, looking at what lung tumor cells need to live and grow.
    04/12/2018 - 4:51 pm | View Website
  • Cancer
    Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body.
    04/11/2018 - 3:45 am | View Website
  • Lung Cancer
    ON THIS PAGE: You will find a list of common tests, procedures, and scans that doctors use to find the cause of a medical problem.Use the menu to see other pages. Doctors use many tests to find, or diagnose, cancer.
    04/11/2018 - 2:11 am | View Website
  • Why I Don’t Favor an Front-Loaded Approach for Most ...
    To many, the recent FDA approval of a combination of chemotherapy and concurrent immunotherapy for the vast majority of patients with advanced (metastatic) non-squamous non-small cell lung cancer (NSCLC) probably seems like a great idea.
    04/10/2018 - 12:00 pm | View Website
  • Lung Cancer
    Lung cancer is a major public health problem. In the United States, 31% of cancer deaths in men and 26% of cancer deaths in women are secondary to lung cancer. The overall prognosis remains poor. Just over one in eight lung cancer patients will be living 5 years after their diagnosis. Most cases of ...
    04/9/2018 - 11:32 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News